Socio-Economic Considerations in Biotechnology Regulation

Karinne Ludlow, Stuart J. Smyth, José Falck-Zepeda

Research output: Book/ReportEdited BookOtherpeer-review

13 Citations (Scopus)

Abstract

Within the context of the Convention on Biological Diversity (CBD), the Cartagena Protocol on Biosafety (CPB) was established as an implementing agreement. The CPB is an international agreement establishing the rights of recipient countries to be notified of and to approve or reject the domestic import and/or production of living modified organisms (LMOs). Decisions regarding import/production are to be on the basis of a biosafety assessment. Article 26.1 of the CPB allows for the (optional) inclusion of socio-economic considerations (SECs) into that biosafety assessment process. This book compiles expert assessments of the issues relevant to SEC assessment of LMOs and fundamental for decisions regarding whether to undertake such assessments at all. It includes an overview of the inclusion of SEC assessment in the regulation of LMOs that looks at the rationale for the inclusion of SECs, in the context of the existing science-based risk assessment systems. This book reviews the various factors that can and have been suggested for inclusion in SEC assessment, and provides a meaningful dialogue about the contrasts, benefits and tradeoffs that are, and will, be created by the potential move to the inclusion of SECs in the regulation of LMOs, making it of interest to both academics and policy-makers.

Original languageEnglish
Place of PublicationNew York NY USA
PublisherSpringer
Number of pages313
ISBN (Electronic)9781461494409
ISBN (Print)9781461494393
DOIs
Publication statusPublished - 1 Jan 2014

Cite this

Ludlow, K., Smyth, S. J., & Falck-Zepeda, J. (2014). Socio-Economic Considerations in Biotechnology Regulation. New York NY USA: Springer. https://doi.org/10.1007/978-1-4614-9440-9
Ludlow, Karinne ; Smyth, Stuart J. ; Falck-Zepeda, José. / Socio-Economic Considerations in Biotechnology Regulation. New York NY USA : Springer, 2014. 313 p.
@book{a7284a20992b420585126e9bf9f401a2,
title = "Socio-Economic Considerations in Biotechnology Regulation",
abstract = "Within the context of the Convention on Biological Diversity (CBD), the Cartagena Protocol on Biosafety (CPB) was established as an implementing agreement. The CPB is an international agreement establishing the rights of recipient countries to be notified of and to approve or reject the domestic import and/or production of living modified organisms (LMOs). Decisions regarding import/production are to be on the basis of a biosafety assessment. Article 26.1 of the CPB allows for the (optional) inclusion of socio-economic considerations (SECs) into that biosafety assessment process. This book compiles expert assessments of the issues relevant to SEC assessment of LMOs and fundamental for decisions regarding whether to undertake such assessments at all. It includes an overview of the inclusion of SEC assessment in the regulation of LMOs that looks at the rationale for the inclusion of SECs, in the context of the existing science-based risk assessment systems. This book reviews the various factors that can and have been suggested for inclusion in SEC assessment, and provides a meaningful dialogue about the contrasts, benefits and tradeoffs that are, and will, be created by the potential move to the inclusion of SECs in the regulation of LMOs, making it of interest to both academics and policy-makers.",
author = "Karinne Ludlow and Smyth, {Stuart J.} and Jos{\'e} Falck-Zepeda",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4614-9440-9",
language = "English",
isbn = "9781461494393",
publisher = "Springer",

}

Socio-Economic Considerations in Biotechnology Regulation. / Ludlow, Karinne; Smyth, Stuart J.; Falck-Zepeda, José.

New York NY USA : Springer, 2014. 313 p.

Research output: Book/ReportEdited BookOtherpeer-review

TY - BOOK

T1 - Socio-Economic Considerations in Biotechnology Regulation

AU - Ludlow, Karinne

AU - Smyth, Stuart J.

AU - Falck-Zepeda, José

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Within the context of the Convention on Biological Diversity (CBD), the Cartagena Protocol on Biosafety (CPB) was established as an implementing agreement. The CPB is an international agreement establishing the rights of recipient countries to be notified of and to approve or reject the domestic import and/or production of living modified organisms (LMOs). Decisions regarding import/production are to be on the basis of a biosafety assessment. Article 26.1 of the CPB allows for the (optional) inclusion of socio-economic considerations (SECs) into that biosafety assessment process. This book compiles expert assessments of the issues relevant to SEC assessment of LMOs and fundamental for decisions regarding whether to undertake such assessments at all. It includes an overview of the inclusion of SEC assessment in the regulation of LMOs that looks at the rationale for the inclusion of SECs, in the context of the existing science-based risk assessment systems. This book reviews the various factors that can and have been suggested for inclusion in SEC assessment, and provides a meaningful dialogue about the contrasts, benefits and tradeoffs that are, and will, be created by the potential move to the inclusion of SECs in the regulation of LMOs, making it of interest to both academics and policy-makers.

AB - Within the context of the Convention on Biological Diversity (CBD), the Cartagena Protocol on Biosafety (CPB) was established as an implementing agreement. The CPB is an international agreement establishing the rights of recipient countries to be notified of and to approve or reject the domestic import and/or production of living modified organisms (LMOs). Decisions regarding import/production are to be on the basis of a biosafety assessment. Article 26.1 of the CPB allows for the (optional) inclusion of socio-economic considerations (SECs) into that biosafety assessment process. This book compiles expert assessments of the issues relevant to SEC assessment of LMOs and fundamental for decisions regarding whether to undertake such assessments at all. It includes an overview of the inclusion of SEC assessment in the regulation of LMOs that looks at the rationale for the inclusion of SECs, in the context of the existing science-based risk assessment systems. This book reviews the various factors that can and have been suggested for inclusion in SEC assessment, and provides a meaningful dialogue about the contrasts, benefits and tradeoffs that are, and will, be created by the potential move to the inclusion of SECs in the regulation of LMOs, making it of interest to both academics and policy-makers.

UR - http://www.scopus.com/inward/record.url?scp=84888858898&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-9440-9

DO - 10.1007/978-1-4614-9440-9

M3 - Edited Book

SN - 9781461494393

BT - Socio-Economic Considerations in Biotechnology Regulation

PB - Springer

CY - New York NY USA

ER -